RAPT Therapeutics, Inc.

NASDAQ:RAPT

1.17 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Operating Activities:
Net Income -129.865-116.798-83.838-69.204-52.892-42.997-36.147-29.115
Depreciation & Amortization 1.2031.2161.0470.9961.1231.331.2371.384
Deferred Income Tax 00000-0.0110.0170.015
Stock Based Compensation 19.93517.09111.2649.9528.6862.0511.170.716
Change In Working Capital 25.9075.499-1.335-4.2982.3444.1330.784-0.114
Accounts Receivables 00000000
Inventory 00000000
Accounts Payables -8.4597.3353.710.9332.390.7361.475-0.08
Other Working Capital 34.366-1.836-5.045-5.231-0.0463.397-0.691-0.034
Other Non Cash Items -0.477-4.0562.0911.5280.2480.02-0.014-0.009
Operating Cash Flow -83.297-97.048-70.771-61.026-40.491-35.474-32.953-27.123
Investing Activities:
Investments In Property Plant And Equipment -0.122-1.125-0.845-0.755-0.398-0.888-3.5-1.124
Acquisitions Net 0044.64580.59287.0370.04500
Purchases Of Investments -82.218-161.497-190.856-164.977-139.334000
Sales Maturities Of Investments 135.042266.755146.21184.38552.297000
Other Investing Activites 00-44.645-80.592-87.0370.04500
Investing Cash Flow 52.702104.133-45.49-81.347-87.435-0.843-3.5-1.124
Financing Activities:
Debt Repayment 00000000
Common Stock Issued 152.0071.447129.788139.4673.6135.5230.2660.246
Common Stock Repurchased 00000000
Dividends Paid 00000000
Other Financing Activities 0.8451.4471.3922.0221.85114.379105.20259.958
Financing Cash Flow 152.8521.447131.18141.48275.46149.90252.73430.102
Other Information:
Effect Of Forex Changes On Cash 00000000
Net Change In Cash 122.2578.53214.919-0.891-52.46513.58516.2811.855
Cash At End Of Period 169.73547.47838.94624.02724.91877.38363.79847.517